Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HPV vaccination intention among unvaccinated international and domestic college students in the U.S.: A cross-sectional survey. | Hum Vaccin Immunother | 2026 | 41528093 | PubTator, text mining | PubMed |
| FDX1-mediated cuproptosis promotes cholestatic liver injury exacerbated by taurocholic acid-enhanced copper accumulation. | Cell Death Discov | 2026 | 41513631 | PubTator, text mining | PubMed |
| Bimodal Mechanical Response of Membrane Necks: Implications for the Nuclear Envelope. | ACS Nano | 2026 | 41436085 | PubTator, text mining | PubMed |
| Mitochondrial uncoupling sensitizes gastric cancer cells to elesclomol-induced cuproptosis via FDX1/DLAT upregulation. | Free Radic Biol Med | 2026 | 41407052 | PubTator, text mining | PubMed |
| Dual-functional copper nanoplatform potentiates cuproptosis through p53 reactivation and metabolic reprogramming. | J Colloid Interface Sci | 2026 | 41352051 | PubTator, text mining | PubMed |
| Dated gene duplications elucidate the evolutionary assembly of eukaryotes. | Nature | 2026 | 41339551 | PubTator, text mining | PubMed |
| Bimetallic Peroxide Nanocomposites-Driven Redox Dyshomeostasis to Activate Sequential Cuproptosis and Pyroptosis for Amplified Tumor Immunotherapy. | Adv Sci (Weinh) | 2026 | 41276916 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in multiple myeloma. | Transl Oncol | 2026 | 41240503 | PubTator, text mining | PubMed |
| Copper-induced duodenal injury: Unveiling the dual role of cuproptosis and ferroptosis via the FDX1/GPX4 axis. | J Nutr Biochem | 2026 | 41224149 | PubTator, text mining | PubMed |
| Novel Ce/Cu-modified black ceramics disrupted mitochondrial dysfunction and tricarboxylic acid cycle to induce cuproptosis in osteosarcoma cells. | Biomater Adv | 2026 | 41218466 | PubTator, text mining | PubMed |
| SIRT7 deficiency promoted cuproptosis-mediated mitochondrial dysfunction and inhibited malignant development of cervical cancer. | Arch Biochem Biophys | 2026 | 41167446 | PubTator, text mining | PubMed |
| The CEBPA/FDX1 axis elevates sensitivity to cuproptosis in lung adenocarcinoma cells. | Biochim Biophys Acta Gen Subj | 2026 | 41135638 | PubTator, text mining | PubMed |
| Stimuli-Responsive CuFeTe2 Nanosheets for Amplified Cuproptosis/Ferroptosis in Triple-Negative Breast Cancer Therapy. | Adv Sci (Weinh) | 2026 | 41133938 | PubTator, text mining | PubMed |
| LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway. | Prostate | 2026 | 41031841 | PubTator, text mining | PubMed |
| Bimetallic nanoconjugate hijack Fe-S clusters to drive a closed-loop cuproptosis-ferroptosis strategy for osteosarcoma inhibition. | J Colloid Interface Sci | 2026 | 40997577 | PubTator, text mining | PubMed |
| A metallic metabolic nano-regulator reprograms the PKM2/HIF-1α/DLAT axis to amplify tumor-specific cuproptosis. | Biomaterials | 2026 | 40815897 | PubTator, text mining | PubMed |
| PIK-III-Mediated Elevation of Thiamine Re-Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1. | Cell Prolif | 2026 | 40741714 | PubTator, text mining | PubMed |
| Clinical significance and immune microenvironment association of cuproptosis-related genes in pan-cancer. | Exp Physiol | 2026 | 40560740 | PubTator, text mining | PubMed |
| Activation of NF-κB signaling in tissue-resident memory T cells promotes recurrent psoriasis in mice. | Front Immunol | 2025 | 41737494 | PubTator, text mining | PubMed |
| Factors influencing recycled materials using in the construction industry in China: an application of the extended theory of planned behavior. | Front Psychol | 2025 | 41726078 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=8